|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 35/02 | (2018.01) |
| C12N 15/86 | (2006.01) | ||
| C12N 5/0783 | (2010.01) | ||
| C12N2740/16043 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K 14/7051 | (2013.01) | ||
| C07K 14/70596 | (2013.01) | ||
| C07K 14/70517 | (2013.01) | ||
| C07K 14/70521 | (2013.01) | ||
| C07K 14/70578 | (2013.01) | ||
| C07K 16/2803 | (2013.01) | ||
| C07K2317/622 | (2013.01) | ||
| C07K2319/03 | (2013.01) | ||
| A61K2039/572 | (2013.01) | ||
| A61K2039/804 | (2018.08) | ||
| A61K2239/48 | (2023.05) | ||
| C12N 5/0636 | (2013.01) | ||
| A61K 39/4631 | (2025.01) | ||
| A61K 39/4611 | (2025.01) | ||
| C12N 5/0646 | (2013.01) | ||
| A61K2239/31 | (2023.05) | ||
| A61K 39/464412 | (2025.01) | ||
| A61K2239/38 | (2023.05) |
| (11) | Patento numeris | 4032978 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20901145.1 |
| Europos patento paraiškos padavimo data | 2020-12-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2022-07-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2025-01-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2020/136241 |
| Data | 2020-12-14 |
| (87) | Numeris | WO 2021/121193 |
| Data | 2021-06-24 |
| (30) | Numeris | Data | Šalis |
| 201911301518 | 2019-12-17 | CN | |
| 202011274810 | 2020-11-16 | CN |
| (72) |
WANG, Jianxiang , CN
WANG, Min , CN
LV, Lulu , CN
SHI, Lin , CN
AN, Na , CN
WANG, Rui , CN
LIU, Yun , CN
|
| (73) |
Juventas Cell Therapy Ltd. ,
Building 5, No. 8, Haitai Development 3rd Road,
Huayuan Industrial Zone,
Binhai High-tech Zone, Tianjin 300384,
CN
|
| (54) | CD19-TARGETED CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF |
| CD19-TARGETED CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF |